Ticker Symbol: SMFR
GeneDx Holdings Corp - Class A
$7.29 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001818331
Company Profile
Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, its innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Standard Industrial Classification Code (SIC code): 8000
Address: N/A
Website: sema4.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.25 - $0.33
Beta: 2.32
52wk. High: $4.65
52wk. Low: $0.22
Ytd. Change 17.74%
50 Day Moving Average: $0.31
200 Day Moving Average: $1.01
Shares Outstanding: 380641510
Valuation
Market Cap: 11.8B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A